These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 15658852

  • 1. Stereoselective synthesis of [L-Arg-L/D-3-(2-naphthyl)alanine]-type (E)-alkene dipeptide isosteres and its application to the synthesis and biological evaluation of pseudopeptide analogues of the CXCR4 antagonist FC131.
    Tamamura H, Hiramatsu K, Ueda S, Wang Z, Kusano S, Terakubo S, Trent JO, Peiper SC, Yamamoto N, Nakashima H, Otaka A, Fujii N.
    J Med Chem; 2005 Jan 27; 48(2):380-91. PubMed ID: 15658852
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and biological evaluation of selective CXCR4 antagonists containing alkene dipeptide isosteres.
    Narumi T, Hayashi R, Tomita K, Kobayashi K, Tanahara N, Ohno H, Naito T, Kodama E, Matsuoka M, Oishi S, Fujii N.
    Org Biomol Chem; 2010 Feb 07; 8(3):616-21. PubMed ID: 20090978
    [Abstract] [Full Text] [Related]

  • 3. Structure-activity relationship study of a CXC chemokine receptor type 4 antagonist, FC131, using a series of alkene dipeptide isosteres.
    Kobayashi K, Oishi S, Hayashi R, Tomita K, Kubo T, Tanahara N, Ohno H, Yoshikawa Y, Furuya T, Hoshino M, Fujii N.
    J Med Chem; 2012 Mar 22; 55(6):2746-57. PubMed ID: 22352868
    [Abstract] [Full Text] [Related]

  • 4. Structure-activity relationships of cyclic peptide-based chemokine receptor CXCR4 antagonists: disclosing the importance of side-chain and backbone functionalities.
    Ueda S, Oishi S, Wang ZX, Araki T, Tamamura H, Cluzeau J, Ohno H, Kusano S, Nakashima H, Trent JO, Peiper SC, Fujii N.
    J Med Chem; 2007 Jan 25; 50(2):192-8. PubMed ID: 17228861
    [Abstract] [Full Text] [Related]

  • 5. Design and synthesis of all diastereomers of cyclic pseudo-dipeptides as mimics of cyclic CXCR4 pentapeptide antagonists.
    Cluzeau J, Oishi S, Ohno H, Wang Z, Evans B, Peiper SC, Fujii N.
    Org Biomol Chem; 2007 Jun 21; 5(12):1915-23. PubMed ID: 17551641
    [Abstract] [Full Text] [Related]

  • 6. SmI2-mediated reduction of gamma,gamma-difluoro-alpha,beta-enoates with application to the synthesis of functionalized (Z)-fluoroalkene-type dipeptide isosteres.
    Otaka A, Watanabe J, Yukimasa A, Sasaki Y, Watanabe H, Kinoshita T, Oishi S, Tamamura H, Fujii N.
    J Org Chem; 2004 Mar 05; 69(5):1634-45. PubMed ID: 14987023
    [Abstract] [Full Text] [Related]

  • 7. Structure-activity relationship studies of the aromatic positions in cyclopentapeptide CXCR4 antagonists.
    Mungalpara J, Zachariassen ZG, Thiele S, Rosenkilde MM, Våbenø J.
    Org Biomol Chem; 2013 Dec 21; 11(47):8202-8. PubMed ID: 24150741
    [Abstract] [Full Text] [Related]

  • 8. Identification of novel low molecular weight CXCR4 antagonists by structural tuning of cyclic tetrapeptide scaffolds.
    Tamamura H, Araki T, Ueda S, Wang Z, Oishi S, Esaka A, Trent JO, Nakashima H, Yamamoto N, Peiper SC, Otaka A, Fujii N.
    J Med Chem; 2005 May 05; 48(9):3280-9. PubMed ID: 15857134
    [Abstract] [Full Text] [Related]

  • 9. Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
    Erchegyi J, Penke B, Simon L, Michaelson S, Wenger S, Waser B, Cescato R, Schaer JC, Reubi JC, Rivier J.
    J Med Chem; 2003 Dec 18; 46(26):5587-96. PubMed ID: 14667213
    [Abstract] [Full Text] [Related]

  • 10. Stereoselective synthesis of (Z)-alkene-containing proline dipeptide mimetics.
    Sasaki Y, Niida A, Tsuji T, Shigenaga A, Fujii N, Otaka A.
    J Org Chem; 2006 Jun 23; 71(13):4969-79. PubMed ID: 16776529
    [Abstract] [Full Text] [Related]

  • 11. Structure-function relationship studies of bovine parathyroid hormone [bPTH(1-34)] analogues containing alpha-amino-iso-butyric acid (Aib) residues.
    Peggion E, Mammi S, Schievano E, Schiebler L, Corich M, Rosenblatt M, Chorev M.
    Biopolymers; 2003 Mar 23; 68(3):437-57. PubMed ID: 12601801
    [Abstract] [Full Text] [Related]

  • 12. Unequivocal synthesis of (Z)-alkene and (E)-fluoroalkene dipeptide isosteres to probe structural requirements of the peptide transporter PEPT1.
    Niida A, Tomita K, Mizumoto M, Tanigaki H, Terada T, Oishi S, Otaka A, Inui K, Fujii N.
    Org Lett; 2006 Feb 16; 8(4):613-6. PubMed ID: 16468724
    [Abstract] [Full Text] [Related]

  • 13. Design, synthesis, and biological evaluation of scaffold-based tripeptidomimetic antagonists for CXC chemokine receptor 4 (CXCR4).
    Zachariassen ZG, Thiele S, Berg EA, Rasmussen P, Fossen T, Rosenkilde MM, Våbenø J, Haug BE.
    Bioorg Med Chem; 2014 Sep 01; 22(17):4759-69. PubMed ID: 25082513
    [Abstract] [Full Text] [Related]

  • 14. Structure-activity relationship study of CXCR4 antagonists bearing the cyclic pentapeptide scaffold: identification of the new pharmacophore.
    Tanaka T, Tsutsumi H, Nomura W, Tanabe Y, Ohashi N, Esaka A, Ochiai C, Sato J, Itotani K, Murakami T, Ohba K, Yamamoto N, Fujii N, Tamamura H.
    Org Biomol Chem; 2008 Dec 07; 6(23):4374-7. PubMed ID: 19005596
    [Abstract] [Full Text] [Related]

  • 15. Peptide bond mimicry by (E)-alkene and (Z)-fluoroalkene peptide isosteres: synthesis and bioevaluation of alpha-helical anti-HIV peptide analogues.
    Oishi S, Kamitani H, Kodera Y, Watanabe K, Kobayashi K, Narumi T, Tomita K, Ohno H, Naito T, Kodama E, Matsuoka M, Fujii N.
    Org Biomol Chem; 2009 Jul 21; 7(14):2872-7. PubMed ID: 19582296
    [Abstract] [Full Text] [Related]

  • 16. Structure-function relationship of novel X4 HIV-1 entry inhibitors - L- and D-arginine peptide-aminoglycoside conjugates.
    Hegde R, Borkow G, Berchanski A, Lapidot A.
    FEBS J; 2007 Dec 21; 274(24):6523-36. PubMed ID: 18028446
    [Abstract] [Full Text] [Related]

  • 17. Certification of the critical importance of L-3-(2-naphthyl)alanine at position 3 of a specific CXCR4 inhibitor, T140, leads to an exploratory performance of its downsizing study.
    Tamamura H, Omagari A, Hiramatsu K, Oishi S, Habashita H, Kanamoto T, Gotoh K, Yamamoto N, Nakashima H, Otaka A, Fujii N.
    Bioorg Med Chem; 2002 May 21; 10(5):1417-26. PubMed ID: 11886804
    [Abstract] [Full Text] [Related]

  • 18. [Structure-activity relationship studies on cyclic RGD peptides utilizing novel alkene dipeptide isosteres].
    Oishi S.
    Yakugaku Zasshi; 2004 May 21; 124(5):269-77. PubMed ID: 15118239
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and evaluation of pseudopeptide analogues of a specific CXCR4 inhibitor, T140: the insertion of an (E)-alkene dipeptide isostere into the betaII'-turn moiety.
    Tamamura H, Hiramatsu K, Miyamoto K, Omagari A, Oishi S, Nakashima H, Yamamoto N, Kuroda Y, Nakagawa T, Otaka A, Fujii N.
    Bioorg Med Chem Lett; 2002 Mar 25; 12(6):923-8. PubMed ID: 11958995
    [Abstract] [Full Text] [Related]

  • 20. Structure-activity relationship study on artificial CXCR4 ligands possessing the cyclic pentapeptide scaffold: the exploration of amino acid residues of pentapeptides by substitutions of several aromatic amino acids.
    Tanaka T, Nomura W, Narumi T, Esaka A, Oishi S, Ohashi N, Itotani K, Evans BJ, Wang ZX, Peiper SC, Fujii N, Tamamura H.
    Org Biomol Chem; 2009 Sep 21; 7(18):3805-9. PubMed ID: 19707686
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.